Herbert Lepor
Urology · New York, NYNPI 1104810902
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,580 of the $19,920 with a category attached, or 68.2%. EDAP Technomed Inc accounts for 64.0% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $10,877, more than ten times the $569 reported in 2019.
Across 60 payments — averaging $332.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EDAP Technomed Inc$13K
- Provepharm Inc.$4K
- Agiliti Surgical, Inc.$541
- Bayer$441
- Urogen Pharma, Inc.$404
- Blue Earth Diagnostics$360
- plus $2K from 11 others
Across 127 payments — averaging $6633.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Blue Earth Diagnostics$802K
- Provepharm Inc.$40K
- Procept Biorobotics Corporation$810
What the payments were for
- Consulting fees$13,58068%
- Travel & lodging$1,2466%
- Food & beverage$5,09426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EDAP Technomed Inc | 13 | $12,750 |
| Provepharm Inc. | 2 | $3,750 |
| Agiliti Surgical, Inc. | 3 | $541 |
| Bayer | 3 | $441 |
| Urogen Pharma, Inc. | 5 | $404 |
| Blue Earth Diagnostics | 7 | $360 |
| Procept Biorobotics Corporation | 2 | $279 |
| AstraZeneca | 2 | $258 |
| AbbVie | 10 | $234 |
| Boston Scientific | 2 | $233 |
| Teleflex LLC | 3 | $232 |
| Pfizer | 1 | $117 |
| Biotissue Holdings Inc. | 1 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $80 |
| Coloplast | 3 | $62 |
| Agiliti Health, Inc. | 1 | $60 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOCAL ONE$10,390
- BLUDIGO$2,250
- Nubeqa$441
- Xofigo$291
- LYNPARZA$258
- JELMYTO$254
- Endocare CryoCare CS System$246
- Koelis TRINITY Fusion Biopsy System$246
- Siemens Healthineers Varian CryoCare$196
- POSLUMA$182
- AQUABEAM SYSTEM$161
- AMS$133
- AquaBeam Robotic System$117
- XTANDI$117
- GENERAL KIDNEY STONE DISEASE$101
How this compares
$19,920 in reported general payments places this provider in the 85th percentile of 952 urology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 69 | $1,835 |
| Tamsulosin Hcl | 93 | $1,579 |
| Silodosin | 13 | $1,540 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 13 | $1,463 |
| Dutasteride | 19 | $550 |
| Ciprofloxacin Hcl | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.